U.S. FDA Confirms Daiichi/Lilly Prasugrel Advisory Committee Review; What Will Panel Membership Entail?

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip